CD5 POSITIVE

Clinical trials for CD5 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new CD5 POSITIVE trials appear

Sign up with your email to follow new studies for CD5 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New drug combo shows promise for Tough-to-Treat lymphoma

Disease control Ongoing

This phase II trial is testing two oral drugs, venetoclax and acalabrutinib, in 32 people with mantle cell lymphoma that has returned or not responded to prior treatment. The goal is to see if the combination can shrink tumors and control the disease. Both drugs work by blocking …

Matched conditions: CD5 POSITIVE

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 09:06 UTC

CD5 POSITIVE

Get alerted when new CD5 POSITIVE trials appear

New drug combo shows promise for Tough-to-Treat lymphoma